merck & co. inc.
Jun 5, 2023, 4:00 PM EDT
India set to release newly developed cervical cancer vaccine soon
The Serum Institute of India (SII) has recently announced that they have successfully developed the world's first cervical cancer vaccine, which will soon hit shelves soon.
Merck’s COVID-19 pill heavily used so far despite concerns
A new COVID-19 pill from Merck & Co. and Ridgeback Biotherapeutics LP has been more widely used than expected since rolling out late last year, though regulators and many doctors consider it a last resort.
Western drugmakers are still providing medicines to Russia
Western health care companies continue supplying medicine, vaccines and medical equipment to Russia.
FDA authorizes second COVID-19 antiviral pill, Merck's molnupiravir
The Food and Drug Administration on Thursday authorized the use of Merck's molnupiravir pill for treating COVID-19, the second such emergency use authorization in two days.
Merck COVID pill effective, experts will review safety: FDA
Federal health regulators say an experimental COVID-19 pill from Merck is effective against the virus, but they will seek input from outside experts on risks of birth defects and other potential problems in pregnant women.
Merck COVID-19 pill sparks calls for access for lower income countries
The plan to roll out Merck & Co's promising antiviral pill to treat COVID-19 risks repeating the inequities of vaccine distribution, potentially leaving the nations with the greatest need once again at the back of the line, international health groups say.
Merck asks FDA to authorize anti-COVID pill for emergency use
Drugmaker Merck asked federal health officials Monday to greenlight its experimental pill against COVID-19, which could make history as the first oral antiviral medicine to treat the harrowing virus.
Merck COVID-19 pill success slams Moderna shares, shakes up health care sector
Positive clinical trial results for Merck & Co's experimental antiviral COVID-19 pill reverberated through the health care sector on Friday, sending the drugmaker's stock price soaring while denting high-flying shares of vaccine companies and makers of other coronavirus therapies.
Merck’s Keytruda gets expanded label for skin cancer treatment
Merck announced Tuesday that the FDA approved an expanded label for Keytruda to treat patients with certain skin cancer that is not curable by surgery or radiation.
Merck’s new CEO Robert Davis begins, after Ken Frazier's retirement
Robert Davis became the new chief executive officer of Merck on Thursday, one day after former CEO Ken Frazier retired.